CFR section

21 CFR 812.150(b)(1): Reports

PART 812-INVESTIGATIONAL DEVICE EXEMPTIONS · Subpart G-Records and Reports

Key facts

Citation 21 CFR 812.150(b)(1)
Section Reports
Part PART 812-INVESTIGATIONAL DEVICE EXEMPTIONS
Subpart Subpart G-Records and Reports
Subchapter 21 CFR H Medical Devices
Product types cited Devices, Drugs, General
Regulation text (excerpt) (1) Unanticipated adverse device effects. A sponsor who conducts an evaluation of an unanticipated adverse device effect under § 812.46(b) shall report the results of such evaluation to FDA and to all reviewing IRB's and participating investigators within 10 working days after the sponsor first receives notice of the effect. Thereafter the sponsor shall submit such additional reports concerning the effect as FDA requests.

At a glance

  • 10–99 Inspections citing this section
  • 1–9 Warning letters citing this section

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About CFR sections cited by the FDA

Title 21 of the Code of Federal Regulations contains the FDA's regulations, including current good manufacturing practice and quality system requirements that inspections cite.

Source: U.S. Code of Federal Regulations (eCFR); citation statistics from FDA inspection and warning-letter data

Browse all CFR sections cited by the FDA